Section 4: Clinical Pharmacy Services 2022
DOI: 10.1136/ejhpharm-2022-eahp.179
|View full text |Cite
|
Sign up to set email alerts
|

4CPS-170 Review of new biomarkers that predict the pharmacokinetics of biologic drugs in inflamatory bowel disease

Abstract: Association between immunerelated side effects and efficacy and benefit of immune checkpoint inhibitorsa systematic review and meta-analysis.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles